LTB - lymphotoxin beta Gene
Species: Macaca mulatta
Gene Type: protein coding
Gene ID: 715518
LTB Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001047150.1 | NP_001040615.1 | lymphotoxin-beta |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
lymphotoxin-beta |
|
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-I0021 | Bepotastine | Antagonist | 99.88% | Unkown |
| HY-A0015 | Bepotastine besilate | Antagonist | 99.77% | Unkown |
| HY-I0021A | Bepotastine tosylate | Antagonist | / | Unkown |
| HY-I0021R | Bepotastine (Standard) | Antagonist | / | Unkown |
Clinical Phase
Bioactive Molecules
(11)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-101438 | Darbufelone | Inhibitor | 99.49% | Phase 3 |
| HY-107608 | Leukotriene B4 | ≥98.0% | Phase 2 | |
| HY-15874 | Fiboflapon | Inhibitor | 99.50% | Phase 2 |
| HY-13628 | Etalocib | 99.03% | Phase 2 | |
| HY-112737 | LY223982 | Inhibitor | 99.65% | Phase 2 |
| HY-19304 | Amelubant | Antagonist | 98.45% | Phase 2 |
| HY-15874A | Fiboflapon sodium | Inhibitor | 98.51% | Phase 2 |
| HY-19166 | E-6700 | Inhibitor | / | Phase 2 |
| HY-19198 | SB-201993 | Antagonist | / | Phase 2 |
| HY-105176 | Ontazolast | Inhibitor | / | Phase 2 |
| HY-19221 | Bay-y-1015 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(99)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-103360 | J-113863 | Antagonist | ≥99.0% | Unkown |
| HY-101408 | Docosatrienoic Acid | 99.9% | Unkown | |
| HY-15744 | LY255283 | Antagonist | 98.04% | Unkown |
| HY-114641A | BIIL-260 hydrochloride | Antagonist | 99.90% | Unkown |
| HY-W073687 | 2,4,6-Triiodophenol | Inducer | 99.52% | Unkown |
| HY-107608S | Leukotriene B4-d4 | 99.14% | Unkown | |
| HY-108396 | γ-Linolenic acid ethyl ester | Antagonist | 99.14% | Unkown |
| HY-N1942 | 5-O-Demethylnobiletin | Inhibitor | 99.91% | Unkown |
| HY-106929 | Moxilubant | Antagonist | 99.83% | Unkown |
| HY-113483 | 20-Carboxy-Leukotriene B4 | Inhibitor | 98.53% | Unkown |
| HY-149589 | 11(Z),14(Z)-Eicosadienoic acid | Inhibitor | ≥98.0% | Unkown |
| HY-112621 | Leukotriene A4 methyl ester | 99.9% | Unkown | |
| HY-14165A | (S)-Veliflapon | Inhibitor | 99.25% | Unkown |
| HY-A0015A | (Rac)-Bepotastine besilate | Inhibitor | 99.52% | Unkown |
| HY-101438A | Darbufelone mesylate | Inhibitor | 99.65% | Unkown |
| HY-10437 | Setileuton | Inhibitor | 99.9% | Unkown |
| HY-112741 | SB-209247 | Antagonist | 99.33% | Unkown |
| HY-112742 | CP-195543 | Antagonist | 98.86% | Unkown |
| HY-115369 | Methyl (13Z,16Z,19Z)-docosatrienoate | 99.9% | Unkown | |
| HY-156736 | HSD17B13-IN-3 | Inhibitor | 99.78% | Unkown |
| HY-161212 | HSD17B13-IN-8 | Inhibitor | 99.97% | Unkown |
| HY-N4267 | Yangambin | 98.27% | Unkown | |
| HY-W341962 | Halometasone | Inhibitor | 98.47% | Unkown |
| HY-12995A | (S)-BI 665915 | Inhibitor | / | Unkown |
| HY-100173 | DW-1350 | Antagonist | / | Unkown |
| HY-101579 | LY 178002 | 99.60% | Unkown | |
| HY-10437A | Setileuton tosylate | Inhibitor | / | Unkown |
| HY-105504 | CI-986 | Inhibitor | / | Unkown |
| HY-105711 | RBx-7796 sodium | Inhibitor | / | Unkown |
| HY-105933 | L-652343 | Inhibitor | / | Unkown |
| HY-106929B | Moxilubant hydrochloride | Antagonist | / | Unkown |
| HY-107608A | 5(S),12(S)-Leukotriene B4 | / | Unkown | |
| HY-112740 | SC-53228 | Antagonist | / | Unkown |
| HY-113479 | 20-Hydroxy-leukotriene B4 | / | Unkown | |
| HY-113484 | Leukotriene B5 | Activator | / | Unkown |
| HY-113879 | 18-Carboxy dinor Leukotriene B4 | / | Unkown | |
| HY-114641 | BIIL-260 | Antagonist | / | Unkown |
| HY-115390 | 14,15-Dehydro Leukotriene B4 | Antagonist | / | Unkown |
| HY-115500 | PL265 | / | Unkown | |
| HY-117896 | SC-50605 | Antagonist | / | Unkown |
| HY-119094 | WAY-196025 | Inhibitor | / | Unkown |
| HY-120539 | Enofelast | Inhibitor | / | Unkown |
| HY-121621 | RO5101576 | / | Unkown | |
| HY-123008 | Reproterol hydrochloride | / | Unkown | |
| HY-123014 | (Rac)-SC-45694 | Agonist | / | Unkown |
| HY-123014A | SC-45694 lithium | / | Unkown | |
| HY-123575 | LY 245769 | Inhibitor | / | Unkown |
| HY-124100 | LTB4 antagonist 4 | / | Unkown | |
| HY-12995 | BI 665915 | Inhibitor | / | Unkown |
| HY-12996 | AZD6642 | Inhibitor | / | Unkown |
| HY-130497 | 12-Oxo-leukotriene B4 | / | Unkown | |
| HY-131651 | Leukotriene B4 ethanolamide | Antagonist | / | Unkown |
| HY-134123 | Lipoxin B4 methyl ester | / | Unkown | |
| HY-13628A | Etalocib sodium | / | Unkown | |
| HY-137350 | 12-epi-LTB4 | Agonist | / | Unkown |
| HY-138050 | Nyasol | Inhibitor | / | Unkown |
| HY-139112 | Leukotriene B4 dimethyl amide | / | Unkown | |
| HY-149082 | LTB4 antagonist 1 | Antagonist | / | Unkown |
| HY-149083 | LTB4 antagonist 2 | Antagonist | / | Unkown |
| HY-149084 | LTB4 antagonist 3 | Antagonist | / | Unkown |
| HY-155204 | LTB4-IN-2 | Inhibitor | / | Unkown |
| HY-155300 | BLT2 antagonist-1 | Antagonist | / | Unkown |
| HY-168015 | 5-Oxo leukotriene B4 | / | Unkown | |
| HY-169434 | LTB | Inhibitor | / | Unkown |
| HY-169435 | TK-OH | 98.36% | Unkown | |
| HY-169436 | Lon-TK | Inhibitor | / | Unkown |
| HY-180411 | SM-15178 | Antagonist | / | Unkown |
| HY-182422 | CGS 23885 | Inhibitor | / | Unkown |
| HY-182696 | CGS 24891 | Inhibitor | / | Unkown |
| HY-185709 | 2-ARA-LysoPtdEtn | / | Unkown | |
| HY-19114 | WY-50295 | Inhibitor | / | Unkown |
| HY-CE00537 | 18-CoA-18-oxo-dinor-LTB4 | / | Unkown | |
| HY-N7801 | (±)5-HEPE | / | Unkown | |
| HY-RS07872 | LTB Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS07873 | LTB4R Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS07874 | Ltb4r Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS07875 | Ltb4r1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS07876 | LTB4R2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W744842 | γ-Linolenic acid ethyl ester-d5 | / | Unkown | |
| HY-W747565 | Leukotriene B4-3-aminopropylamide | / | Unkown | |
| HY-106929R | Moxilubant (Standard) | Antagonist | / | Unkown |
| HY-107608S1 | Leukotriene B4-d5 | / | Unkown | |
| HY-113628 | ABT-080 | Inhibitor | 98.42% | Unkown |
| HY-117557 | LY306669 | Antagonist | / | Unkown |
| HY-117706 | LY 292728 | Antagonist | / | Unkown |
| HY-117854 | SB 201146 | Antagonist | / | Unkown |
| HY-118156 | L-699333 | / | Unkown | |
| HY-118848 | A63162 | Inhibitor | / | Unkown |
| HY-120606 | A-78773 | Inhibitor | / | Unkown |
| HY-122536 | Ricinelaidic acid | / | Unkown | |
| HY-14162 | AM103 free acid | Inhibitor | / | Unkown |
| HY-141635 | cis-11,14-Eicosadienoic acid methyl ester | 98.05% | Unkown | |
| HY-174587 | Human LTB mRNA | / | Unkown | |
| HY-N11072 | Tremulacin | Inhibitor | 96.41% | Unkown |
| HY-RS16892 | Ltb Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23334 | Ltb Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-U00170 | Bunaprolast | Inhibitor | / | Unkown |
| HY-U00263 | LY210073 | Antagonist | / | Unkown |
| HY-U00299 | LTB4-IN-1 | Inhibitor | / | Unkown |